Optimising TRIUMPH with 6·25 mg chlorthalidone

Lancet Glob Health. 2020 Feb;8(2):e175. doi: 10.1016/S2214-109X(19)30535-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents
  • Chlorthalidone*
  • Cost-Benefit Analysis
  • Humans
  • Hypertension*
  • Sri Lanka

Substances

  • Antihypertensive Agents
  • Chlorthalidone